Medtronic raises guidance and shares trade higher on NYSE
Published on 06/25/2026 at 21:32 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-25, 19:32.
Medtronic plc (IE00BTN1Y115) reported fourth-quarter and full-year fiscal 2026 results on NYSE, and the release said the company posted its highest annual revenue growth in 10 years. StockTitan’s summary of the update also showed the ordinary shares under the MDT ticker on the New York Stock Exchange.
What Medtronic said
The company’s latest update centers on fiscal 2026 results, not a minor product note. StockTitan listed the filing among Medtronic’s newest items on June 25, 2026, including the full-year results and several portfolio updates tied to neurovascular, robotic surgery, and cardiac ablation.
That mix matters because Medtronic’s revenue base reaches across cardiovascular, neuroscience, medical surgical, and diabetes segments. The latest results give investors a current read on that portfolio before the next earnings step.
Peers on NYSE
The NYSE anchor is clear, and Medtronic sits in the same U.S. large-cap healthcare universe as Abbott, Boston Scientific, and Johnson & Johnson. That peer set gives traders a quick way to compare growth, margin profile, and product-cycle momentum.
Wall Street Online’s Medtronic page put the German-market-referenced quote at 72.11 euros at 17:34:38, and it also listed the stock’s 7-day performance at plus 6.76 percent. The same page showed analyst sentiment with 38 percent Strong Buy, 16 percent Buy, and 41 percent Hold.
All news and analysis on Medtronic shares
The June 25 result release sits beside the company’s recent portfolio moves, which makes the current Medtronic tape easier to place in a broader healthcare context.
The business behind the stock
Medtronic sells medical technology across cardiology, neuroscience, medical surgical, and diabetes care. Its portfolio includes pacemakers, defibrillators, surgical robotics, and therapy systems used in hospitals and clinics worldwide.
Where the shares stand
The Medtronic shares (IE00BTN1Y115) trade on 2026-06-25, 17:34:38 on the relevant European market reference at 72.11 euros.
Key data on the Medtronic shares
- Company: Medtronic plc
- ISIN: IE00BTN1Y115
- Ticker: MDT
- Trading venue: NYSE
- Price (as of 2026-06-25, 17:34:38): 72.11 EUR
- Sector / industry: Healthcare equipment
- Index membership: S&P 500
This article is for information only and does not constitute investment advice.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
